We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Plastic particles in medicine: A systematic review of exposure and effects to human health
AI summary Read the abstract
Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.
Single-use plastics (SUPs) have become an essential constituent of our daily life. It is being exploited in numerous pharmaceutical and healthcare applications. Despite their advantages and widespread use in the pharma and medical sectors, the potential clinical problems of plastics, especially the release of micro-nanoplastics (MNPs) and additives from medical plastics (e.g. bags, containers, and administrative sets) and sorption of drugs remain understudied. Certainly, the MNPs are multifaceted stressors that cause detrimental effects to the ecosystem and human health. The origin and persistence of MNPs in pharmaceutical products, their administration to humans, endurance and possible health implication, translocation, and excretion have not been reviewed in detail. The prime focus of this article is to conduct a systematic review on the leaching of MNPs and additives from pharmaceutical containers/administrative sets and their interaction with the pharmaceutical constituents. This review also explores the primary and secondary routes of MNPs entry from healthcare plastic products and their potential health hazards to humans. Furthermore, the fate of plastic waste generated in hospitals, their disposal, and associated MNPs release to the environment, along with preventive, and alternative measures are discussed herein.
More Papers Like This
Micro-plastics as a source of contaminaion in pharmaceuticals
AI summary Read the abstract
This review examined how microplastics contaminate pharmaceutical manufacturing environments and products, discussing the potential health risks of plastic particle exposure through medicines and the pathways by which microplastics enter pharmaceutical supply chains.
Microplastic particles and infusion therapy — Evidence, implications, and unanswered questions
AI summary Read the abstract
This review highlights infusion therapy via medical devices and pharmaceutical containers as a significant but often overlooked route of microplastic exposure in humans. The study emphasizes that despite strict regulations, advances in clinical research have not been fully integrated into current industry testing standards, and calls for a standardized, multi-method approach to microplastic detection and risk assessment in medical settings.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
AI summary Read the abstract
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Iatrogenic Microplastic Exposure: A Possible and Underrecognized Healthcare-Associated Exposure Framework in Human Medicotoxicological Risk
AI summary Read the abstract
Medical interventions—including intravenous fluids, implantable devices, and polymer-coated oral medications—represent an underrecognized fourth route of microplastic and nanoplastic exposure, with vulnerable populations such as neonates and ICU patients facing disproportionate risk. This conceptual review calls for re-evaluation of plastic use in healthcare settings to reduce iatrogenic nanoplastic burden in patients.
Microplastic-drug Interactions: Unveiling Combined Effects on Biological Systems
AI summary Read the abstract
This review examines how microplastics interact with pharmaceutical drugs in biological systems, exploring the combined toxic effects of co-exposure to polypropylene, polyethylene, polystyrene, polyvinyl chloride, and polyamide particles alongside common medications.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.